Peptic Ulcer Disease

🩺What is Peptic Ulcer Disease?

The Rockall score was developed by Rockall et al. in 1996 based on data from the UK national audit of upper gastrointestinal hemorrhage. It consists of three pre-endoscopy clinical variables (age, presence of shock, and comorbidities) and two endoscopic variables (diagnosis and stigmata of recent hemorrhage). The total score ranges from 0 to 11, with higher scores indicating greater mortality risk. The score is widely used in clinical practice to guide triage decisions, determine the urgency of endoscopy, and predict patient outcomes. A score of 0-2 suggests low mortality risk (<3%), 3-4 moderate risk (5-10%), 5-6 high risk (10-20%), and 7-11 very high risk (30-60%).

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Peptic Ulcer Disease:

• Rockall Score for Upper GI Bleeding

  The Rockall score (also known as the admission Rockall score or full Rockall score) is a validated clinical scoring system used to predict mortality risk in patients presenting with upper gastrointestinal bleeding. It combines clinical parameters (age, shock, comorbidity) with endoscopic findings (diagnosis, stigmata of recent hemorrhage) to stratify patients into low, moderate, high, and very high mortality risk categories.

• Glasgow-Blatchford Score for Upper GI Bleeding

  The Glasgow-Blatchford Score (GBS) is a validated pre-endoscopy risk stratification tool for patients presenting with upper gastrointestinal bleeding. It identifies patients at low risk (<0.5% needing intervention) who may be suitable for outpatient management without urgent endoscopy.

🧬Diagnostic Logic & Scoring Breakdown

The Rockall score is calculated by summing points from five variables. Age: <60 years = 0, 60-79 years = 1, ≥80 years = 2. Shock: No shock (SBP ≥100 mmHg and pulse <100 bpm) = 0, Tachycardia (pulse ≥100 bpm, SBP ≥100 mmHg) = 1, Hypotension (SBP <100 mmHg) = 2. Comorbidity: None = 0, CHF/CAD/renal/liver disease = 2, Renal failure/liver disease/metastatic cancer = 3. Endoscopic diagnosis: Mallory-Weiss tear or no lesion identified = 0, All other diagnoses = 1, Upper GI malignancy = 2. Stigmata of recent hemorrhage: None or spot only = 0, Blood in lumen/adherent clot/visible vessel = 1. Total score ranges from 0-11. The score stratifies patients into four mortality risk groups: Low (0-2, <3% mortality), Moderate (3-4, 5-10%), High (5-6, 10-20%), Very High (7-11, 30-60%). Note: The "clinical" or "admission" Rockall score uses only the first three variables (age, shock, comorbidity) without endoscopic findings, while the "full" Rockall score includes all five variables.

📢Clinical Significance & Implications

The Rockall score is a well-validated tool for predicting mortality in upper GI bleeding, one of the most common gastroenterological emergencies with an estimated annual incidence of 50-150 per 100,000 population. The score aids in clinical decision-making by identifying patients who may benefit from early discharge (Rockall 0-2) versus those requiring intensive monitoring and urgent endoscopic intervention (Rockall ≥5). The score has been externally validated in multiple populations and healthcare settings. Key strengths include its simplicity, use of routinely available clinical and endoscopic data, and clear mortality risk stratification. Limitations include reduced discriminative performance in certain subgroups (e.g., variceal bleeding) and the requirement for endoscopic findings for the full score. The clinical or admission Rockall score (using only age, shock, and comorbidity) can be calculated immediately upon presentation without endoscopic data.

💡 Clinical Assessment Scenario Example

A 75-year-old man presents with hematemesis and melena. Vital signs: BP 95/60 mmHg, pulse 110 bpm (shock score = 2). He has a history of CAD and CKD (comorbidity score = 3). Age 75 (score = 1). Endoscopy reveals a duodenal ulcer with a visible vessel (diagnosis score = 1, stigmata score = 1). Total Rockall score = 1 + 2 + 3 + 1 + 1 = 8 (Very High risk, 30-60% mortality). This patient requires ICU admission, immediate endoscopic hemostasis, IV PPI therapy, and close monitoring for rebleeding.

💊Common Medications & Interventions

The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Peptic Ulcer Disease:

🔗Related Diseases & Conditions

These conditions are clinically associated with Peptic Ulcer Disease through shared risk-scoring calculators and assessment tools:

• Upper Gastrointestinal Bleeding
• Mallory-Weiss Syndrome
• Esophageal Varices

⚠️Clinical Assessment Pitfalls

• ❌ Mistake: Using the full Rockall score without endoscopic findings available

  ✅ Correction: The full Rockall score requires endoscopic variables (diagnosis and stigmata). Use the clinical/admission Rockall score (age, shock, comorbidity only) for initial risk stratification before endoscopy. The clinical score ranges from 0-7.

• ❌ Mistake: Applying Rockall score to variceal bleeding without adjustment

  ✅ Correction: The Rockall score was primarily developed and validated for non-variceal upper GI bleeding. In variceal bleeding, use disease-specific scores such as the Child-Pugh score or MELD score for mortality prediction, as Rockall may underestimate risk in this population.

• ❌ Mistake: Using GBS to predict mortality rather than need for intervention

  ✅ Correction: GBS was designed and validated to predict the need for clinical intervention (blood transfusion, endoscopic therapy, or surgery), not specifically mortality. Consider the Rockall or AIMS65 scores for mortality prediction.

• ❌ Mistake: Interpreting a moderate score (1-5) as low risk without clinical correlation

  ✅ Correction: Only a GBS of 0 reliably identifies patients suitable for discharge. Scores 1-5 require clinical assessment and may still need admission, especially in elderly patients or those with significant comorbidities.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Peptic Ulcer Disease; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

❓Frequently Asked Questions

📚Evidence-Based References